昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

休市中 05-09 16:08:07

10.280

-0.220

-2.10%

最高10.680	最低10.160	成交量335.91万
今开10.580	昨收10.500	日振幅4.95%
总市值77.00亿	流通市值12.23亿	总股本7.49亿
成交额3,457万	换手率2.82%	流通股本1.19亿
市净率0.89	ROE0.85%	每股收益0.11
52周最高17.600	52周最低6.310	市盈率95.69
股息0.17	股息收益率0.02	ROA1.04%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":10.28,"timestamp":1746778087035,"preClose":10.5,"halted":0,"volume":3359052,"delay":0,"floatShares":119000000,"shares":749000000,"eps":0.10743417214421845,"marketStatus":"休市中","change":-0.22,"latestTime":"05-09 16:08:07","open":10.58,"high":10.68,"low":10.16,"amount":34571245,"amplitude":0.049524,"askPrice":10.3,"askSize":6900,"bidPrice":10.28,"bidSize":39000,"shortable":0,"etf":0,"ttmEps":0.10743417214421845,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":7,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":10.5,"dividendRate":0.016664,"openAndCloseTimeList":[[1746754200000,1746763200000],[1746766800000,1746777600000]],"volumeRatio":0.7012295020586027,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":16.13,"timestamp":1746774000000,"preClose":16.35,"halted":0,"volume":19242100,"delay":0,"premium":"-40.68"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"2534177882","title":"昭衍新药05月09日主力净流出70.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2534177882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534177882?lang=zh_cn&edition=full","pubTime":"2025-05-09 16:15","pubTimestamp":1746778525,"startTime":"0","endTime":"0","summary":"05月09日, 昭衍新药股价跌2.10%，报收10.28元，成交金额3457.1万元，换手率2.82%，振幅4.95%，量比0.70。昭衍新药今日主力资金净流出70.6万元，上一交易日主力净流入216.6万元。该股近5个交易日上涨4.58%，主力资金累计净流出159.6万元；近20日主力资金累计净流入475.4万元，其中净流入天数为8日。该股主力净额占比0.06%，港股市场排名2573/2645。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174940a477f913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174940a477f913&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2533791644","title":"昭衍新药盘中异动 早盘快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533791644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533791644?lang=zh_cn&edition=full","pubTime":"2025-05-08 09:36","pubTimestamp":1746668165,"startTime":"0","endTime":"0","summary":"2025年05月08日早盘09时36分，昭衍新药股票出现异动，股价急速拉升5.03%。昭衍新药股票所在的生物技术行业中，整体跌幅为0.04%。报告期内，公司实现营业总收入20.18亿元，同比下降15.07%；归母净利润7407.5万元，同比下降81.34%；经营活动产生的现金流量净额为3.37亿元，同比下降45.76%；据报告显示，昭衍新药基本每股收益为0.1元，加权平均净资产收益率为0.9%。数据显示，2024年公司加权平均净资产收益率为0.9%，较上年同期下降3.89个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508093605a4760459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508093605a4760459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","06127"],"gpt_icon":0},{"id":"2533604509","title":"昭衍新药05月07日遭主力抛售258.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533604509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533604509?lang=zh_cn&edition=full","pubTime":"2025-05-07 16:15","pubTimestamp":1746605735,"startTime":"0","endTime":"0","summary":"05月07日, 昭衍新药股价跌1.58%，报收9.94元，成交金额6478.2万元，换手率5.40%，振幅5.45%，量比2.10。昭衍新药今日主力资金净流出258.0万元，上一交易日主力净流出47.6万元。该股近5个交易日上涨3.32%，主力资金累计净流出35.6万元；近20日主力资金累计净流出201.8万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171242a475224c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507171242a475224c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","06127","BK1576"],"gpt_icon":0},{"id":"2532724069","title":"每周股票复盘：昭衍新药（603127）一季度归母净利润同比增长115.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532724069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532724069?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:51","pubTimestamp":1746035468,"startTime":"0","endTime":"0","summary":"截至2025年4月25日收盘，昭衍新药报收于15.54元，较上周的15.52元上涨0.13%。本周，昭衍新药4月23日盘中最高价报16.19元。4月21日盘中最低价报15.26元。本周关注点业绩披露要点：昭衍新药一季度归母净利润同比增长115.11%业绩披露要点昭衍新药2025年一季报显示，公司主营收入2.87亿元，同比下降11.54%；归母净利润4111.95万元，同比上升115.11%；扣非净利润2566.26万元，同比上升109.14%；负债率13.96%，投资收益123.59万元，财务费用-1912.34万元，毛利率28.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100000623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127"],"gpt_icon":0},{"id":"2531719877","title":"昭衍新药（603127）2025年一季报简析：净利润增115.11%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2531719877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531719877?lang=zh_cn&edition=full","pubTime":"2025-04-30 06:21","pubTimestamp":1745965274,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期昭衍新药发布2025年一季报。截至本报告期末，公司营业总收入2.87亿元，同比下降11.54%，归母净利润4111.95万元，同比上升115.11%。本报告期昭衍新药三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达33.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000006644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127"],"gpt_icon":0},{"id":"2531271309","title":"12家医疗服务公司发布一季报，昭衍新药、睿智医药等传“捷报”","url":"https://stock-news.laohu8.com/highlight/detail?id=2531271309","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531271309?lang=zh_cn&edition=full","pubTime":"2025-04-29 16:19","pubTimestamp":1745914740,"startTime":"0","endTime":"0","summary":"截至4月29日，医疗服务行业已有39家公司披露2025年一季报，其中诺泰生物、睿智医药、昭衍新药、光正眼科和成都先导五家公司的净利润实现翻倍。这些公司在不同领域实现了显著的业绩增长，主要得益于收入增加、成本控制和市场需求的变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504291634349749d758&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504291634349749d758&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300149","BK0077","BK0216","603127","06127"],"gpt_icon":0},{"id":"2531821605","title":"港股创新药板块盘初走高，泰凌医药(01011.HK)涨近7%，石药集团(01093.HK)涨超4%，百济神州(06160","url":"https://stock-news.laohu8.com/highlight/detail?id=2531821605","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531821605?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:49","pubTimestamp":1745891393,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1610","LU0140636845.USD","LU0417516738.SGD","LU0359201612.USD","LU1226288253.USD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1960683339.HKD","BK1576","LU0051755006.USD","LU0823426308.USD","YANG","LU0856984785.SGD","LU0708995583.HKD","IE00B5MMRT66.SGD","02269","01093","688235","06160","06127","LU0516423091.SGD","BK4614","603127","LU0456846285.SGD","LU1226287792.SGD","BK1588","HSCEI","LU0348825331.USD","LU1226287529.USD","01011","LU1008478684.HKD","LU1880383366.USD","LU2328871848.SGD","LU1720050803.USD","HSTECH","06978","159992","07226","LU0819121731.USD","BK1161","LU0588546209.SGD","ONC","BK1583","LU1688375341.USD","IE0008369823.USD","LU0880133367.SGD","LU1152091754.HKD","LU0823426480.USD","SG9999004220.SGD","BK1141"],"gpt_icon":0},{"id":"2531296795","title":"智通港股早知道 | 工信部发布2025年汽车标准化工作要点 超前开展飞行汽车等新业态标准化需求研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2531296795","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531296795?lang=zh_cn&edition=full","pubTime":"2025-04-29 07:25","pubTimestamp":1745882740,"startTime":"0","endTime":"0","summary":"工信部发布2025年汽车标准化工作要点：超前开展飞行汽车等新业态标准化需求研究工信部发布2025年汽车标准化工作要点。其中提出，前瞻布局前沿领域标准研究。分析评估前沿技术发展趋势和潜在应用场景，识别研判未来汽车标准化发展方向，推动制定及发布车用人工智能、固态电池、电动汽车换电等标准子体系，启动数据治理及应用等新领域标准体系建设，超前开展飞行汽车等新业态标准化需求研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320264.USD","BK1147","02696","BK1574","BK1583","BK1501","YANG","BK4614","LU2045819591.USD","HK0000306685.HKD","LU2242644610.SGD","HSTECH","LU2125910500.SGD","LU0052750758.USD","03908","02359","BK1576","BK1564","HSCEI","LU1046422090.SGD","06127","SG9999002828.SGD","HK0000306701.USD","BK1161","LU0708995583.HKD","LU0320764599.SGD","01548","HK0000320223.HKD","BK1516","BK1141","06855"],"gpt_icon":1},{"id":"2530283833","title":"昭衍新药(06127.HK)：2025年第一季度归属股东净利润4111.95万元，同比实现扭亏为盈。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530283833","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530283833?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:18","pubTimestamp":1745846302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0216","BK1576","06127","603127","BK1141"],"gpt_icon":0},{"id":"2530092405","title":"昭衍新药(06127)公布第一季度业绩 归母净利约4111.95万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2530092405","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530092405?lang=zh_cn&edition=full","pubTime":"2025-04-28 20:07","pubTimestamp":1745842045,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)公布2025年第一季度业绩，营业收入约2.87亿元，同比减少11.54%;归属于上市公司股东的净利润约4111.95万元，同比扭亏为盈;基本每股收益0.05元。公告称，净利增长主要系上年同期生物资产公允价值变动损失较多所致。受市场环境变化、行业竞争格局调整及客户需求波动等因素综合影响，本报告期新签订单金额约为人民币 4.3 亿，截止本报告期末，在手订单金额约为人民币 22 亿。公司在手订单执行受多种因素的影响，请投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603127","BK0216","06127","BK1141","BK1576"],"gpt_icon":0},{"id":"1166357920","title":"港股异动 | 生物医药板块持续高开，康方生物涨5%，本周已累涨近30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166357920","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166357920?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:27","pubTimestamp":1745544452,"startTime":"0","endTime":"0","summary":"本周五（4月25日）港股盘初，生物医药板块持续高开， $康方生物(09926)$ 涨5%，本周已累涨近30%， $云顶新耀-B(01952)$ 涨近5%：","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","06996","02269","02696","06622","09995","06160","06127","02359","01801","03759","06606","06185","06618","00241"],"gpt_icon":0},{"id":"2529325679","title":"昭衍新药04月24日遭主力抛售459万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529325679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529325679?lang=zh_cn&edition=full","pubTime":"2025-04-24 16:15","pubTimestamp":1745482537,"startTime":"0","endTime":"0","summary":"04月24日, 昭衍新药股价跌2.54%，报收9.96元，成交金额8188万元，换手率6.73%，振幅6.85%，量比2.20。昭衍新药今日主力资金净流出459万元，上一交易日主力净流出187万元。该股近5个交易日下跌2.35%，主力资金累计净流出349万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1621万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424165802a46516b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424165802a46516b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","06127"],"gpt_icon":0},{"id":"2529210343","title":"昭衍新药04月22日获主力加仓214万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529210343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529210343?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:16","pubTimestamp":1745309793,"startTime":"0","endTime":"0","summary":"04月22日, 昭衍新药股价涨2.55%，报收10.04元，成交金额3370万元，换手率2.83%，振幅3.37%，量比0.31。昭衍新药今日主力资金净流入214万元，上一交易日主力净流入210万元。该股近5个交易日下跌1.76%，主力资金累计净流入772万元；近20日主力资金累计净流出1311万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171259a6c38bfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171259a6c38bfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","06127"],"gpt_icon":0},{"id":"2529707897","title":"昭衍新药上周获融资净买入1264.42万元，居两市第232位","url":"https://stock-news.laohu8.com/highlight/detail?id=2529707897","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529707897?lang=zh_cn&edition=full","pubTime":"2025-04-21 07:54","pubTimestamp":1745193244,"startTime":"0","endTime":"0","summary":"4月21日，沪深两融数据显示，昭衍新药上周累计获融资净买入额1264.42万元，居两市第232位，上周融资买入额1.42亿元，偿还额1.30亿元。资金流方面，昭衍新药近5日主力资金流出542.53万元，区间跌幅0.28%；近10日主力资金流出2.83亿元，区间跌幅6.73%。通过天眼查大数据分析，北京昭衍新药研究中心股份有限公司共对外投资了20家企业，参与招投标项目42次，知识产权方面有商标信息67条，专利信息55条，此外企业还拥有行政许可43个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/21075449696581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","603127","BK1141","BK1576","06127"],"gpt_icon":0},{"id":"2528192890","title":"动物实验需求或将减少 “猴茅”昭衍新药受冲击","url":"https://stock-news.laohu8.com/highlight/detail?id=2528192890","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528192890?lang=zh_cn&edition=full","pubTime":"2025-04-19 03:48","pubTimestamp":1745005680,"startTime":"0","endTime":"0","summary":"近期，FDA 官方网站宣布计划逐步取消单抗和其他药物的动物实验要求。动物实验或将被替代根据公告，FDA将转而采用一系列新兴的替代技术，包括基于AI毒性预测模型、细胞系以及实验室环境下的类器官毒性测试等。“猴周期”下行实际上，昭衍新药的命运与实验猴价格深度绑定。当FDA新政与国内药监机构类器官技术推广形成合围，其核心业务面临需求减少的风险。昭衍新药方面如是说。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041904092894da6fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041904092894da6fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1141","603127","BK1576"],"gpt_icon":0},{"id":"2528966796","title":"易方达基金管理有限公司减持昭衍新药(06127)306.43万股 每股作价约9.92港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528966796","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528966796?lang=zh_cn&edition=full","pubTime":"2025-04-17 17:46","pubTimestamp":1744883202,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月11日，易方达基金管理有限公司减持昭衍新药(06127)306.43万股，每股作价为9.921港元，总金额约为3040.09万港元。减持后最新持股数目为620.24万股，持股比例为5.21%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","06127","BK1576","BK0216","603127"],"gpt_icon":0},{"id":"2528839760","title":"昭衍新药04月17日主力净流入210万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2528839760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528839760?lang=zh_cn&edition=full","pubTime":"2025-04-17 16:15","pubTimestamp":1744877728,"startTime":"0","endTime":"0","summary":"04月17日, 昭衍新药股价涨0.20%，报收9.79元，成交金额2696万元，换手率2.31%，振幅2.15%，量比0.24。昭衍新药今日主力资金净流入210万元，上一交易日主力净流出129万元。该股近5个交易日下跌16.95%，主力资金累计净流入190万元；近20日主力资金累计净流出1638万元，其中净流出天数为12日。该股主力净额占比0.18%，港股市场排名29/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417170025a6bdb3ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417170025a6bdb3ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2528780451","title":"A股CRO概念震荡反弹，双成药业6天5板，诺思格涨超10%，河化股份、新天地、宣泰医药、昭衍新药等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528780451","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528780451?lang=zh_cn&edition=full","pubTime":"2025-04-17 10:16","pubTimestamp":1744856163,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["399300","BK1141","BK0066","002693","000953","BK0216","BK0239","159982","301277","603127","301333","688247","BK0004","BK0077","BK0071","BK1576","06127","BK0010"],"gpt_icon":0},{"id":"2527256329","title":"昭衍新药：公司不存在应披露而未披露的信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2527256329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527256329?lang=zh_cn&edition=full","pubTime":"2025-04-16 15:34","pubTimestamp":1744788883,"startTime":"0","endTime":"0","summary":"证券之星消息，昭衍新药(603127)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好！今天贵司股价无故跌停，盘后显示机构大幅出逃，请问贵司是否有应披露而未披露信息？贵司一季报业绩是否提前被机构提前知晓，机构选择借多年前利空消息抢跑，导致股价大跌，谢谢昭衍新药回复：您好！公司不存在应披露而未披露的信息，可查阅公司于4月12日披露的相关公告，谢谢。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041600018983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK0216","06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2527891422","title":"昭衍新药盘中异动 快速跳水5.10%报9.680港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527891422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527891422?lang=zh_cn&edition=full","pubTime":"2025-04-16 11:04","pubTimestamp":1744772663,"startTime":"0","endTime":"0","summary":"2025年04月16日早盘11时04分，昭衍新药股票出现波动，股价大幅下跌5.10%。截至发稿，该股报9.680港元/股，成交量245.24万股，换手率2.06%，振幅5.69%。昭衍新药股票所在的生物技术行业中，整体跌幅为3.67%。随着猴子涨价，昭衍新药业绩一飞冲天，2022年公司营收同比增长49.54%至22.68亿元，归母净利润大幅增长92.71%至10.74亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416110423a45a832b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416110423a45a832b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","06127"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0426},{"period":"1month","weight":-0.0375},{"period":"3month","weight":0.0731},{"period":"6month","weight":-0.021},{"period":"1year","weight":0.0773},{"period":"ytd","weight":0.0995}],"compareEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":0.1285},{"period":"3month","weight":0.0821},{"period":"6month","weight":0.1032},{"period":"1year","weight":0.2336},{"period":"ytd","weight":0.14}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。非临床研究服务包括药物安全性评价、药代动力学研究以及药理和药效学研究。临床试验及相关服务包括临床合同研究组织服务、一期临床研究协作单位 (CRU)，以及生物分析服务。实验模型业务主要包括啮齿类及非人灵长类动物。该公司在国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.111191},{"month":2,"riseRate":0.75,"avgChangeRate":0.13794},{"month":3,"riseRate":0.4,"avgChangeRate":-0.007631},{"month":4,"riseRate":0.2,"avgChangeRate":-0.110122},{"month":5,"riseRate":0.8,"avgChangeRate":0.03197},{"month":6,"riseRate":0.5,"avgChangeRate":0.026858},{"month":7,"riseRate":0.75,"avgChangeRate":0.036307},{"month":8,"riseRate":0,"avgChangeRate":-0.164063},{"month":9,"riseRate":0.5,"avgChangeRate":0.001124},{"month":10,"riseRate":0.25,"avgChangeRate":-0.061345},{"month":11,"riseRate":0.5,"avgChangeRate":0.080654},{"month":12,"riseRate":0.5,"avgChangeRate":-0.057443}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}